Specific targeting of acetylcholinesterase and butyrylcholinesterase recognition sites. Rational design of novel, selective, and highly potent cholinesterase inhibitors.

No abstract is available for this paper.

• Publication year

  2003

• Venue

  Journal of Medicinal Chemistry

• Publication date

  2003-01-02

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1021/JM0255668PMID 12502352
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Click chemistry in situ: acetylcholinesterase as a reaction vessel for the selective assembly of a femtomolar inhibitor from an array of building blocks.

  2002cited by this paper
• Novel and potent tacrine-related hetero- and homobivalent ligands for acetylcholinesterase and butyrylcholinesterase.

  2001cited by this paper
• The key role of butyrylcholinesterase during neurogenesis and neural disorders: an antisense-5'butyrylcholinesterase-DNA study.

  2000cited by this paper
• SAR of 9-amino-1,2,3,4-tetrahydroacridine-based acetylcholinesterase inhibitors: synthesis, enzyme inhibitory activity, QSAR, and structure-based CoMFA of tacrine analogues.

  2000cited by this paper
• Huprine X is a novel high-affinity inhibitor of acetylcholinesterase that is of interest for treatment of Alzheimer's disease.

  2000cited by this paper
• Evaluation of short-tether bis-THA AChE inhibitors. A further test of the dual binding site hypothesis.

  1999cited by this paper
• Heterodimeric tacrine-based acetylcholinesterase inhibitors: investigating ligand-peripheral site interactions.

  1999cited by this paper
• Trp82 and Tyr332 are involved in two quaternary ammonium binding domains of human butyrylcholinesterase as revealed by photoaffinity labeling with [3H]DDF.

  1998cited by this paper
• Differences in active site gorge dimensions of cholinesterases revealed by binding of inhibitors to human butyrylcholinesterase.

  1997cited by this paper
• Highly Potent, Selective, and Low Cost Bis-tetrahydroaminacrine Inhibitors of Acetylcholinesterase

  1996cited by this paper
• Conversion of acetylcholinesterase to butyrylcholinesterase: modeling and mutagenesis.

  1992cited by this paper

• Innovative approaches in acetylcholinesterase inhibition: a pathway to effective Alzheimer’s disease treatment

  2025cites this paper
• Benzylpiperidine-pyridazin-3(2H)-one derivatives as potential multifunctional agents against Alzheimer's disease.

  2025cites this paper
• Design, Synthesis, Characterization and In Vitro Evaluation of Anticholinesterase and Antioxidant Activities of Thiazole–Piperazine Sulphonamide Hybrids

  2025cites this paper
• Implications of the non‐neuronal cholinergic system for therapeutic interventions of inflammatory skin diseases

  2024cites this paper
• Novel multifunctional tacrine–donepezil hybrids against Alzheimer's disease: Design synthesis and bioactivity studies

  2024cites this paper
• Molecular insights into vasicine and butyrylcholinesterase interactions: A complimentary biophysical, multi-spectroscopic, and computational study.

  2024cites this paper
• Acetylcholinesterase: A Versatile Template to Coin Potent Modulators of Multiple Therapeutic Targets

  2024cites this paper
• Investigation of spirooxindole-pyrrolidine derivatives as acetylcholinesterase inhibitors using molecular docking/dynamics simulations, bioisosteric replacement, MEP, and ADME/Tox properties

  2023cites this paper
• Dual-target ligand discovery for Alzheimer’s disease: triphenylphosphoranylidene derivatives as inhibitors of acetylcholinesterase and β-amyloid aggregation

  2023influential citation
• Synthesis and biological study of new galanthamine-peptide derivatives designed for prevention and treatment of Alzheimer’s disease

  2022cites this paper
• A highly effective and stable butyrylcholinesterase inhibitor with multi-faceted neuroprotection and cognition improvement.

  2022cites this paper
• Toward the cholinesterase inhibition potential of TADDOL derivatives: Seminal biological and computational studies

  2022cites this paper
• Identifying Possible AChE Inhibitors from Drug-like Molecules via Machine Learning and Experimental Studies

  2022cites this paper
• Sustainable Drug Discovery of Multi-Target-Directed Ligands for Alzheimer’s Disease

  2021cites this paper
• In-vitro evaluation of antioxidant and anticholinesterase activities of novel pyridine, quinoxaline and s-triazine derivatives.

  2021cites this paper
• Centrally Active Multitarget Anti-Alzheimer Agents Derived from the Antioxidant Lead CR-6.

  2020cites this paper
• A Multi-layered Variable Selection Strategy for QSAR Modeling of Butyrylcholinesterase Inhibitors.

  2020cites this paper
• Interactions of dye compounds that are structurally related to methylene blue with acetylcholinesterase and butyrylcholinesterase

  2020cites this paper
• Discovery of a Potent Dual Inhibitor of Acetylcholinesterase and Butyrylcholinesterase with Antioxidant Activity that Alleviates Alzheimer-like Pathology in Old APP/PS1 Mice.

  2020cites this paper
• Alzheimer’s disease and its current treatments; Is there a possibility for a cure?

  2019cites this paper
• Structure-based virtual screening leading to discovery of highly selective butyrylcholinesterase inhibitors with solanaceous alkaloid scaffolds.

  2019cites this paper
• Scientific Considerations in the Approval of Complex Generics

  2019cites this paper
• Molecular dynamics approach for behavior assessment of chitosan nanoparticles in carrying of donepezil and rivastigmine drug molecules

  2019cites this paper
• Highly Selective Butyrylcholinesterase Inhibitors with Tunable Duration of Action by Chemical Modification of Transferable Carbamate Units Exhibit Pronounced Neuroprotective Effect in an Alzheimer's Disease Mouse Model.

  2019cites this paper
• Discovery, molecular dynamic simulation and biological evaluation of structurally diverse cholinesterase inhibitors with new scaffold through shape-based pharmacophore virtual screening.

  2019cites this paper
• Design, synthesis and bioevaluation of tricyclic fused ring system as dual binding site acetylcholinesterase inhibitors.

  2019cites this paper
• Comprehensive review of mechanisms of pathogenesis involved in Alzheimer's disease and potential therapeutic strategies.

  2019cites this paper
• Development of Multifunctional Molecules as Potential Therapeutic Candidates for Alzheimer's Disease, Parkinson's Disease, and Amyotrophic Lateral Sclerosis in the Last Decade.

  2018cites this paper
• A molecular approach in drug development for Alzheimer's disease.

  2018cites this paper
• Spectroscopic investigation on the interaction characteristics and inhibitory activities between baicalin and acetylcholinesterase

  2018cites this paper
• Increasing Polarity in Tacrine and Huprine Derivatives: Potent Anticholinesterase Agents for the Treatment of Myasthenia Gravis

  2018cites this paper
• Recent progress in the identification of selective butyrylcholinesterase inhibitors for Alzheimer's disease.

  2017cites this paper
• Discovery of Potent Dual Binding Site Acetylcholinesterase Inhibitors via Homo‐ and Heterodimerization of Coumarin‐Based Moieties

  2017cites this paper
• Tacrine, Trolox and Tryptoline as Lead Compounds for the Design and Synthesis of Multi-target Agents for Alzheimer’s Disease Therapy

  2017influential citation
• Mannich‐Benzimidazole Derivatives as Antioxidant and Anticholinesterase Inhibitors: Synthesis, Biological Evaluations, and Molecular Docking Study

  2017cites this paper
• New Schiff bases derived from benzyl carbazate with alkyl and heteroaryl ketones

  2017cites this paper
• Multitarget compounds bearing tacrine- and donepezil-like structural and functional motifs for the potential treatment of Alzheimer's disease.

  2017cites this paper
• Synthesis of novel 5-(aroylhydrazinocarbonyl)escitalopram as cholinesterase inhibitors.

  2017cites this paper
• 5‐Amino‐6,7,8,9‐Tetrahydrobenzo[b][1,8]Naphthyridin‐2(1H)‐One: The first Example of a new Family of HuperTacrines for Alzheimer's Disease Therapy

  2017cites this paper
• Amaryllidaceae alkaloids with new framework types from Zephyranthes candida as potent acetylcholinesterase inhibitors.

  2017cites this paper
• Running head: ANTITUMOR ACTIVITY OF NEW RITUXIMAB VARIANTS

  2017cites this paper
• Application of Molecular Modelling studies to the search of novel approaches for neuroprotection and stem cells applications

  2016cites this paper
• Molecular modeling and docking calculations of 4-acyloxy-biphenyl-4′-N-butylcarbamates as potential inhibitors of human butyrylcholinesterase

  2016cites this paper
• Novel series of tacrine-tianeptine hybrids: Synthesis, cholinesterase inhibitory activity, S100B secretion and a molecular modeling approach.

  2016cites this paper
• Novel multi-target-directed ligands for Alzheimer's disease: Combining cholinesterase inhibitors and 5-HT6 receptor antagonists. Design, synthesis and biological evaluation.

  2016cites this paper
• Zephycandidine A, the First Naturally Occurring Imidazo[1,2-f]phenanthridine Alkaloid from Zephyranthes candida, Exhibits Significant Anti-tumor and Anti-acetylcholinesterase Activities

  2016cites this paper
• Benzylpiperidine-Linked Diarylthiazoles as Potential Anti-Alzheimer's Agents: Synthesis and Biological Evaluation.

  2016cites this paper
• Multi-Targeting Derivatives For Alzheimer’s Disease: Utilization of Quinazoline Ring Scaffolds

  2016influential citation
• Tricyclic phenothiazine and phenoselenazine derivatives as potential multi-targeting agents to treat Alzheimer's disease

  2015cites this paper
• Novel Levetiracetam Derivatives That Are Effective against the Alzheimer-like Phenotype in Mice: Synthesis, in Vitro, ex Vivo, and in Vivo Efficacy Studies.

  2015cites this paper
• Synthesis of novel triazoles and a tetrazole of escitalopram as cholinesterase inhibitors.

  2015cites this paper
• Combating HER2-overexpressing breast cancer through induction of calreticulin exposure by Tras-Permut CrossMab

  2015cites this paper
• Molecular docking of different inhibitors and activators to butyrylcholinesterase

  2015influential citation
• Development of HuperTacrines as non-toxic, cholinesterase inhibitors for the potential treatment of Alzheimer's disease.

  2015cites this paper
• Structural dynamics of acetylcholinesterase and its implications in reactivators design

  2015influential citation
• From Protein Communication to Drug Discovery.

  2015cites this paper
• Design of Multi-Target Compounds as AChE, BACE1, and Amyloid-β1-42 Oligomerization Inhibitors: In Silico and In Vitro Studies

  2014cites this paper
• Toxicological and pharmacological evaluation, antioxidant, ADMET and molecular modeling of selected racemic chromenotacrines {11-amino-12-aryl-8,9,10,12-tetrahydro-7H-chromeno[2,3-b]quinolin-3-ols} for the potential prevention and treatment of Alzheimer's disease.

  2014cites this paper
• Kinetics of butyrylcholinesterase inhibition by an ethanolic extract of Shorea robusta

  2014cites this paper
• Novel tacrine/acridine anticholinesterase inhibitors with piperazine and thiourea linkers.

  2014cites this paper
• Inhibition of flavonoids on acetylcholine esterase: binding and structure-activity relationship.

  2014cites this paper
• Buchwald–Hartwig Amination Approach for the Synthesis of Functionalized 1,2,3,4-Tetrahydroacridine Derivatives

  2014cites this paper
• Syntheses of coumarin-tacrine hybrids as dual-site acetylcholinesterase inhibitors and their activity against butylcholinesterase, Aβ aggregation, and β-secretase.

  2014cites this paper
• Pharmacophore based 3DQSAR of phenothiazines as specific human butyrylcholinesterase inhibitors for treatment of Alzheimer's disease.

  2014cites this paper
• Discovery and SAR study of piperidine-based derivatives as novel influenza virus inhibitors.

  2014cites this paper
• Design, synthesis and biological evaluation of benzylisoquinoline derivatives as multifunctional agents against Alzheimer's disease.

  2014cites this paper
• New molecular scaffolds for the design of Alzheimer’s acetylcholinesterase inhibitors identified using ligand- and receptor-based virtual screening

  2013cites this paper
• The multifactorial nature of Alzheimer's disease for developing potential therapeutics.

  2013cites this paper
• A review on cholinesterase inhibitors for Alzheimer’s disease

  2013cites this paper
• Simultaneous separation, identification and activity evaluation of three butyrylcholinesterase inhibitors from Plumula nelumbinis using on-line HPLC-UV coupled with ESI-IT-TOF-MS and BChE biochemical detection.

  2013cites this paper
• Synthesis, molecular docking and antiamnesic activity of selected 2- naphthyloxy derivatives.

  2013cites this paper
• Recent advances in the multitarget‐directed ligands approach for the treatment of Alzheimer's disease

  2013cites this paper
• Acetylcholinesterase Inhibitors: Structure Based Design, Synthesis, Pharmacophore Modeling, and Virtual Screening

  2013cites this paper
• Divergent structure-activity relationships of structurally similar acetylcholinesterase inhibitors.

  2013cites this paper
• Predictions of BuChE Inhibitors Using Support Vector Machine and Naive Bayesian Classification Techniques in Drug Discovery

  2013cites this paper
• Increased susceptibility of brain acetylcholinesterase activity to methylmalonate in young rats with renal failure

  2013cites this paper
• Galantamine-based hybrid molecules with acetylcholinesterase, butyrylcholinesterase and γ-secretase inhibition activities.

  2012cites this paper
• Synthesis, biological assessment, and molecular modeling of racemic 7-aryl-9,10,11,12-tetrahydro-7H-benzo[7,8]chromeno[2,3-b]quinolin-8-amines as potential drugs for the treatment of Alzheimer's disease.

  2012cites this paper
• Huprine-tacrine heterodimers as anti-amyloidogenic compounds of potential interest against Alzheimer's and prion diseases.

  2012cites this paper
• Synthesis, design and biological evaluation of novel highly potent tacrine congeners for the treatment of Alzheimer's disease.

  2012cites this paper
• Huprine Derivatives as Sub‐Nanomolar Human Acetylcholinesterase Inhibitors: From Rational Design to Validation by X‐ray Crystallography

  2012cites this paper
• Design, synthesis, and bioevaluation of benzamides: novel acetylcholinesterase inhibitors with multi-functions on butylcholinesterase, Aβ aggregation, and β-secretase.

  2012cites this paper
• Probing the mid-gorge of cholinesterases with spacer-modified bivalent quinazolinimines leads to highly potent and selective butyrylcholinesterase inhibitors.

  2011cites this paper
• Stereo‐specific inhibition of acetyl‐ and butyryl‐cholinesterases by enantiomers of cis,cis‐decahydro‐2‐naphthyl‐N‐n‐butylcarbamate

  2011cites this paper
• Optimization of 1,2,3,4-tetrahydroacridin-9(10H)-ones as antimalarials utilizing structure-activity and structure-property relationships.

  2011cites this paper
• A hydrazide linker strategy for heterobivalent compounds as ortho- and allosteric ligands of acetylcholine-binding proteins.

  2011cites this paper
• Pd-catalyzed amination as an alternative to nucleophilic aromatic substitution for the synthesis of N-alkyltacrines and analogues.

  2011cites this paper
• Molecular, Biochemical, and Toxicological Evaluation of Anticholinesterases for control of the Malaria Mosquito, Anopheles gambiae

  2011cites this paper
• Synthesis, biological assessment and molecular modeling of 14-aryl-10,11,12,14-tetrahydro-9H-benzo[5,6]chromeno[2,3-b]quinolin-13-amines.

  2011cites this paper
• Cholinergic and neuroprotective drugs for the treatment of Alzheimer and neuronal vascular diseases. II. Synthesis, biological assessment, and molecular modelling of new tacrine analogues from highly substituted 2-aminopyridine-3-carbonitriles.

  2011cites this paper
• Chemical and Pharmacological Studies on Enantiomerically Pure p‐Methoxytacripyrines, Promising Multi‐Target‐Directed Ligands for the Treatment of Alzheimer’s Disease

  2011cites this paper
• Structural determinants of the multifunctional profile of dual binding site acetylcholinesterase inhibitors as anti-Alzheimer agents.

  2010cites this paper
• Bivalent 5,8,9,13b-tetrahydro-6H-isoquino[1,2-a]isoquinolines and -isoquinolinium salts: novel heterocyclic templates for butyrylcholinesterase inhibitors.

  2010cites this paper
• Synthesis and insecticidal activity of novel carbamate derivatives as potential dual-binding site acetylcholinesterase inhibitors.

  2010cites this paper
• Targeting Alzheimer's disease: Novel indanone hybrids bearing a pharmacophoric fragment of AP2238.

  2010cites this paper
• Multipotent drugs with cholinergic and neuroprotective properties for the treatment of Alzheimer and neuronal vascular diseases. I. Synthesis, biological assessment, and molecular modeling of simple and readily available 2-aminopyridine-, and 2-chloropyridine-3,5-dicarbonitriles.

  2010cites this paper
• Disposable potentiometric sensors for monitoring cholinesterase activity.

  2010cites this paper
• Novel tacrine-8-hydroxyquinoline hybrids as multifunctional agents for the treatment of Alzheimer's disease, with neuroprotective, cholinergic, antioxidant, and copper-complexing properties.

  2010cites this paper
• Tacrine derivatives and Alzheimer's disease.

  2010cites this paper
• Long-acting anticholinesterases for myasthenia gravis: synthesis and activities of quaternary phenylcarbamates of neostigmine, pyridostigmine and physostigmine.

  2010cites this paper